Article
Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis
10 Jan 2008
Abstract excerpt
The mechanisms underlying the susceptibility of individuals with caspase recruitment domain 15 (CARD15) mutations and corresponding abnormalities of nucleotide-binding oligomerization domain 2 (NOD2) protein to Crohn disease are still poorly understood. One possibility is based on previous studies showing that muramyl dipeptide (MDP) activation of NOD2 negatively regulates TLR2 responses and that absence of such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
